AbstractBackground & objectives: The purpose of this study is to assess the accuracy of these two imaging modalities in proposing a biopsy for BIRADS III and higher lesions, and to ascertain whether Sonoelastogram breast is a better option than Dynamic MR Mammography in this regard.
Methods: A prospective cohort study was conducted from January 2018 to January 2019 in the Out Patient Department of Radiology at Sambhram Institute of Medical Sciences and Research, Bangalore, Karnataka, India, involving 50 patients (one male and 49 female) with breast masses. All cases underwent conventional B mode ultrasound; only those categorized as BIRADS III and above had further examination using Sonoelastography and Dynamic contrast enhanced MR mammography. A Tsukuba elastographic score of 1–5 was determined based on the lesion's uptake of contrast in the introduction and twilight phases. Dynamic MR kinetic curve patterns 1–3 were examined.
Result: The HPE Final Diagnosis of the analyzed breast pathologies shows that 22 of the lesions are malignant and 28 are benign. Dynamic MR mammography curve patterns are 89.5% sensitive and 96.2% specific. Sonoelastography has a 68.4 percent sensitivty and a 92.3 percent specificity. Both the Dynamic MRI Mammogram and Sonoelastography are very accurate at diagnosing breast cancer, with 93.3% and 82.2%, respectively. Final Diagnosis of Breast Masses by HPE Compares Favorably to Curve Analysis of Dynamic MR Mammograms and Sonoelastography.
Conclusion: For evaluating breast lesions, sonoelastography and MR Mammography are both helpful techniques; the latter could reduce the number of unnecessary biopsies conducted. We discovered that in terms of both sensitivity and specificity, MR Mammography performed better than Sonoelastography.
